Year |
Citation |
Score |
2019 |
Osterman MT, Gordon IO, Davis EM, Ciorba M, Glover SC, Abraham B, Khan F, Guo X, Yee EU, Allard FD, Claggett B, Shen B, Liu JJ. Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease. Inflammatory Bowel Diseases. PMID 31553433 DOI: 10.1093/Ibd/Izz222 |
0.326 |
|
2019 |
Tang Y, Tan SA, Iqbal A, Li J, Glover SC. Genotypic Variant and Increased Tyrosine Phosphorylation of STAT3 in IL-23 Responsive Innate Lymphoid Cells during Pathogenesis of Crohn's Disease. Journal of Immunology Research. 2019: 9406146. PMID 31321245 DOI: 10.1155/2019/9406146 |
0.323 |
|
2019 |
Zhang D, Glover SC, Liu W, Liu X, Lai J. Small Bowel Pyogenic Granuloma With Cytomegalovirus Infection in a Patient With Crohn's Disease (Report of a Case and Review of the Literature). In Vivo (Athens, Greece). 33: 251-254. PMID 30587632 DOI: 10.21873/Invivo.11468 |
0.336 |
|
2019 |
Davis EM, Zhang D, Glover SC, Stappenbeck T, Wang S, Liu JJ. P128 INHIBITION OF INTESTINAL EPITHELIAL CELL PYROPTOSIS AND ASSOCIATED MUCOSAL BARRIER DEFECTS IS A POTENTIAL THERAPEUTIC MECHANISM OF ACTION FOR MESALAMINE IN IBD Gastroenterology. 156: S88. DOI: 10.1053/J.Gastro.2019.01.204 |
0.326 |
|
2019 |
Hamilton M, Konnikova L, Pozdnyakova O, Lyons JJ, Milner JD, Shirley JF, Ryan LK, Tang Y, Snapper SB, Glover SC. Tu1845 – Identification of a Unique Population of Gi Mast Cells in a Subset of Patients with Mast Cell Activation Syndrome Gastroenterology. 156: S-1146. DOI: 10.1016/S0016-5085(19)39831-2 |
0.309 |
|
2019 |
Osterman MT, Gordon I, Davis EM, Ciorba MA, Glover SC, Abraham BP, Khan F, Guo X, Yee E, Allard FD, Claggett B, Shen B, Liu JJ. 535 – Ileal Biopsy Epithelial Cell Pyroptosis Predicts Clinical Response to Vedolizumab Therapy in Crohn's Disease Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)37065-9 |
0.307 |
|
2018 |
Stoner PL, Kamel A, Ayoub F, Tan S, Iqbal A, Glover SC, Zimmermann EM. Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support. Gastroenterology Research and Practice. 2018: 7890161. PMID 30344603 DOI: 10.1155/2018/7890161 |
0.301 |
|
2018 |
Li J, Glover SC. Innate Lymphoid Cells in Inflammatory Bowel Disease. Archivum Immunologiae Et Therapiae Experimentalis. PMID 30155762 DOI: 10.1007/S00005-018-0519-5 |
0.343 |
|
2018 |
Stewart DC, Berrie D, Li J, Liu X, Rickerson C, Mkoji D, Iqbal A, Tan S, Doty AL, Glover SC, Simmons CS. Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease. Plos One. 13: e0200377. PMID 29995938 DOI: 10.1371/Journal.Pone.0200377 |
0.324 |
|
2017 |
Westerveld D, Grajo J, Beattie L, Glover S. Vedolizumab: a novel medical intervention in the treatment of primary sclerosing cholangitis. Case Reports. 2017. PMID 28501828 DOI: 10.1136/Bcr-2017-220351 |
0.312 |
|
2017 |
Afrin LB, Fox RW, Zito SL, Choe L, Glover SC. Successful Targeted Treatment of Mast Cell Activation Syndrome with Tofacitinib. European Journal of Haematology. PMID 28382662 DOI: 10.1111/Ejh.12893 |
0.3 |
|
2017 |
Davis EM, Kaufmann Y, Goyne H, Wang Y, Chen T, Theus S, Lai K, Glover SC, Claggett BL, Jobin C, Liu JJ. Pyroptosis of Intestinal Epithelial Cells is Crucial to the Development of Mucosal Barrier Dysfunction and Intestinal Inflammation Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)33282-1 |
0.335 |
|
2016 |
Graves CL, Li J, LaPato M, Shapiro MR, Glover SC, Wallet MA, Wallet SM. Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes. Frontiers in Immunology. 7: 679. PMID 28119693 DOI: 10.3389/Fimmu.2016.00679 |
0.32 |
|
2016 |
Nathoo S, Hood WA, Keihanian S, Collinsworth AL, Glover SC. Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn's disease: a case report. Journal of Medical Case Reports. 10: 264. PMID 27663846 DOI: 10.1186/S13256-016-1036-Y |
0.302 |
|
2016 |
Tang Y, Li J, Doty A, Glover SC. Mo1935 Identification of Differential Human Innate Lymphoid Cell Composition in the Inflamed Gut of Inflammatory Bowel Disease Patients Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)32777-9 |
0.34 |
|
2015 |
Li J, Bharadwaj SS, Guzman G, Vishnubhotla R, Glover SC. ROCK I Has More Accurate Prognostic Value than MET in Predicting Patient Survival in Colorectal Cancer. Anticancer Research. 35: 3267-73. PMID 26026086 |
0.698 |
|
2014 |
Li J, Glover SC, Gjymishk A. Sa1916 Increased Expression of ROCK I and Met in Colorectal Cancer Is Associated With Decreased Patient Survival Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)61185-9 |
0.342 |
|
2013 |
Gjymishka A, Coman RM, Brusko TM, Glover SC. Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes. Immunotherapy. 5: 1357-66. PMID 24283846 DOI: 10.2217/Imt.13.130 |
0.304 |
|
2013 |
Yu HJ, Serebryannyy LA, Fry M, Greene M, Chernaya O, Hu WY, Chew TL, Mahmud N, Kadkol SS, Glover S, Prins G, Strakova Z, de Lanerolle P. Tumor stiffness is unrelated to myosin light chain phosphorylation in cancer cells. Plos One. 8: e79776. PMID 24224004 DOI: 10.1371/Journal.Pone.0079776 |
0.368 |
|
2012 |
Vishnubhotla R, Bharadwaj S, Sun S, Metlushko V, Glover SC. Treatment with Y-27632, a ROCK Inhibitor, Increases the Proinvasive Nature of SW620 Cells on 3D Collagen Type 1 Matrix. International Journal of Cell Biology. 2012: 259142. PMID 22690219 DOI: 10.1155/2012/259142 |
0.73 |
|
2012 |
Akhavein M A, Patel NR, Muniyappa PK, Glover SC. Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility. Gastroenterology Research and Practice. 2012: 950582. PMID 22577375 DOI: 10.1155/2012/950582 |
0.33 |
|
2012 |
Bharadwaj SS, Nekrasov V, Vishnubhotla R, Foster C, Glover SC. Commensal E. coli Strains Uniquely Alter the ECM Topography Independent of Colonic Epithelial Cells Journal of Biomaterials and Nanobiotechnology. 3: 70-78. DOI: 10.4236/Jbnb.2012.31009 |
0.745 |
|
2012 |
Glover SC, Bharadwaj S. Mo1624 Mechanical Induction of Epithelial to Mesenchymal Transition in Colon Cancer Cells Gastroenterology. 142. DOI: 10.1016/S0016-5085(12)62479-2 |
0.402 |
|
2011 |
Bharadwaj S, Vishnubhotla R, Shan S, Chauhan C, Cho M, Glover SC. Higher molecular weight polyethylene glycol increases cell proliferation while improving barrier function in an in vitro colon cancer model. Journal of Biomedicine & Biotechnology. 2011: 587470. PMID 21976966 DOI: 10.1155/2011/587470 |
0.757 |
|
2011 |
Glover SC, Vishnubhotla RV, Cho M, Bharadwaj S. Increased ECM Density Increases Rock's Ability to Modulate Colon Cancer Proliferation but Does Not Change Its Impact on Invasion Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)63436-7 |
0.723 |
|
2010 |
Rapier R, Huq J, Vishnubhotla R, Bulic M, Perrault CM, Metlushko V, Cho M, Tay RT, Glover SC. The extracellular matrix microtopography drives critical changes in cellular motility and Rho A activity in colon cancer cells. Cancer Cell International. 10: 24. PMID 20667086 DOI: 10.1186/1475-2867-10-24 |
0.749 |
|
2010 |
Vishnubhotla RV, Bharadwaj S, Nekrasov V, Glover SC. W1769 Colon Cancer and Rho Kinase: Is Rock-II Really the Most Active Rock? Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)63389-6 |
0.711 |
|
2010 |
Nekrasov V, Titushkin I, Cho M, Glover SC. T1750 In Vitro and In Vivo Evidence in Support of Differentiation of Colon Cancer Stem Cells Into Adipocyte-Like Cells Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)62628-5 |
0.361 |
|
2009 |
Glover SC, Nekrasov V, Vishnubhotla RV, Bharadwaj S, Foster CL. T1754 Commensal E. coli Strains Have the Ability to Alter the ECM Topography Independtant of Colonic Epithelial Cells Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)62635-4 |
0.721 |
|
2009 |
Glover SC, Chauhan C, Foster CL, Bharadwaj S, Vishnubhotla RV, Nekrasov V. S2056 Polyethylene Glycol (PEG) Prevents Against the Pro-Invasive Effects of Both Commensal and Pathogenic E. coli and May Increase Chemoresponsiveness of Colon Cancer Cells By Increasing Proliferation Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)61471-2 |
0.753 |
|
2008 |
Glover SC, Bulic M, Vishnubhotla RV, Viswanathan VK, Cho M, Roxas JL, Mecum R, Titushkin I. S2057 A Loss of Symbiosis with Certain Strains of Commensal E Coli Leads to Increased Colon Cancer Invasion in An In Vitro Colon Cancer Model Via Activation of Rac and MMP-1 Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)61427-4 |
0.746 |
|
2008 |
Mutlu EA, Glover SC, Gillevet PM, Llor X, Quander CR, Sikaroodi M, Engen P, Bracamonte S, Keshavarzian A. S2007 Bacterial Microbiota Fingerprints Are Altered in Colon Cancer Gastroenterology. 134: A-296. DOI: 10.1016/S0016-5085(08)61377-3 |
0.387 |
|
2007 |
Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, Glover SC. ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Laboratory Investigation; a Journal of Technical Methods and Pathology. 87: 1149-58. PMID 17876296 DOI: 10.1038/Labinvest.3700674 |
0.747 |
|
2005 |
Glover S, Nathaniel R, Shakir L, Perrault C, Anderson RK, Tran-Son-Tay R, Benya RV. Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling. American Journal of Physiology. Gastrointestinal and Liver Physiology. 288: G1274-82. PMID 15890713 DOI: 10.1152/Ajpgi.00108.2004 |
0.361 |
|
2005 |
Matusiak D, Glover S, Nathaniel R, Matkowskyj K, Yang J, Benya RV. Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon. American Journal of Physiology. Gastrointestinal and Liver Physiology. 288: G718-28. PMID 15528253 DOI: 10.1152/Ajpgi.00156.2004 |
0.305 |
|
2004 |
Glover S, Delaney M, Dematte C, Kornberg L, Frasco M, Tran-Son-Tay R, Benya RV. Phosphorylation of focal adhesion kinase tyrosine 397 critically mediates gastrin-releasing peptide's morphogenic properties. Journal of Cellular Physiology. 199: 77-88. PMID 14978737 DOI: 10.1002/Jcp.10456 |
0.408 |
|
2003 |
Matkowskyj KA, Keller K, Glover S, Kornberg L, Tran-Son-Tay R, Benya RV. Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 51: 1041-8. PMID 12871985 DOI: 10.1177/002215540305100807 |
0.357 |
|
2003 |
Glover SC, Tretiakova MS, Carroll RE, Benya RV. Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression. Molecular Carcinogenesis. 37: 5-15. PMID 12720295 DOI: 10.1002/Mc.10117 |
0.372 |
|
2003 |
Glover S, Matkowskyj KA, Keller K, Benya RV. Expression of Grp and its receptor in well differentiated human colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407 Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)83093-7 |
0.346 |
|
2003 |
Glover S, Delaney M, Keller K, Tran-Son-tay R, Benya RV. FAK phosphorylation at Y397 mediates GRP's morphogenic properties of enhancing cell attachment and promoting tissue remodeling Gastroenterology. 124: A23. DOI: 10.1016/S0016-5085(03)80115-4 |
0.304 |
|
Show low-probability matches. |